Results 231 to 240 of about 116,133 (341)

Immunopathogenic Mechanisms in Connective Tissue Disease-Associated Interstitial Lung Disease: Incessant Loop of Immunity to Fibrosis. [PDF]

Int J Mol Sci
Lee JH, Jang JH, Lee S, Her M.
europepmc   +1 more source

The importance of considering progression speed in systemic sclerosis—associated interstitial lung diseases: application of 2022 and 2024 clinical practice guidelines for progressive pulmonary fibrosis, a retrospective cohort study [PDF]

Anaïs Roeser, Pierre‐Yves Brillet, Stéphane Tran Ba, F. Caux, Robin Dhôte, Hilario Nunès, Y. Uzunhan   +6 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances. [PDF]

Int J Mol Sci
Kurilin V, Fisher M, Obleukhova I, Sennikov S.   +3 more
europepmc   +1 more source

Lowered Angiogeneic Capability of Peripheral Blood Lymphocytes in Progressive Systemic Sclerosis (Scleroderma)

, 1984
Marek Kamiński, Sławomir Majewski, Stefania Jabłońska, M. Pawińska   +3 more
openalex   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

First Korean Case of <i>C9orf72</i>-Related Amyotrophic Lateral Sclerosis With Progressive Supranuclear Palsy-Like Features. [PDF]

J Clin Neurol
Choi SJ, Park H, Sung JJ.
europepmc   +1 more source

Progressive Systemic Sclerosis Associated with Systemic Lupus Erythematosus

, 1984
Takashi Imamura, Chidori Asagami, Norimasa Hara, Michio Shiraishi, Hidesuke Fujita   +4 more
openalex   +1 more source

An extensive primary myocardial fibrosis in progressive systemic sclerosis. A case report with autopsy findings.

, 1982
Kazuhide Yamaoki, Yoshio Yazaki, Hiroshi Matsunaga, Terunao Ashida, Ryozo Nagai, Yasuyoshi Ohuchi, Seigo Ueda, Yuzo Miyakawa, Kinori Kosaka   +8 more
openalex   +2 more sources

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source